Technical Service:techserv@altogen.com or submit electronic form below. Scientific and technical questions are reviewed and answered by our R&D scientists.
Orders and Customer Support:orders@altogen.com or submit electronic form below. To place an order, account set-up, or to check order status. Accounting and billing questions.
Custom Services (Altogen Biosystems):corporate@altogen.comGeneration of stable lines. Custom RNAi services.
Altogen Biosystems (Corporate):corporate@altogen.comInterested to distribute Altogen Biosystems products? Are you interested to commercialize your research product, or looking for collaborative partner for SBIR/STTR biotechnology project?
Technical Support
Purchasing and Order Related Questions
About Us
Altogen Biosystems is a life sciences company dedicated to the development, marketing and manufacture of cell type specific transfection reagents. Efficient delivery of DNA, RNA, siRNA, and microRNA molecules enabled by advanced formulation of reagents and peculiar design of protocols.
Altogen Biosystems offers a complete transfection system for a broad range of cancer cell lines and primary cells. All reagents are functionally tested to be highly reproducible, serum compatible, induce low toxicity, and can be used for co-transfection applications, and in vivo experiments.
Visit Altogen Biosystems Transfection Resource: RNAi applications (siRNA transfection, microRNA transfection, plasmid DNA transfection), stable and transient transfection, delivery methods, electroporation, microinjection, dendrimer-based, non-viral and virus-mediated gene delivery, liposome and non-liposomal reagents.
Altogen Research Services provide specialized biotechnology and pharmaceutical services, including - generation of stable cell lines, RNA Interference (RNAi) services, assay development, screening and transfection services. Generation of stably-expressing cancer cell lines and primary cells can be very expensive and time-consuming. Altogen Services offers generation of stable cell lines by transforming the cell line of choice to stably express gene of interest or shRNA-encoding construct. Cloning and shRNA expression services are available.